Relativity Study Between Idiopathic Ventricular Arrhythmia and Sex Hormone Levels in Different Stages of Menstrual Cycle
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether the occurrence of idiopathic right ventricular outflow tract(RVOT) arrhythmia is relative to sex hormone levels in different stages of female menstrual cycle
| Condition |
|---|
|
Ventricular Premature Complexes |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Relativity Study Between Idiopathic Ventricular Arrhythmia and Sex Hormone Levels in Different Stages of Menstrual Cycle |
- number and duration of right ventricular outflow tract arrhythmia [ Time Frame: one month ] [ Designated as safety issue: Yes ]
- sex hormone levels [ Time Frame: one month ] [ Designated as safety issue: Yes ]
Biospecimen Retention: Samples With DNA
whole blood, serum
| Estimated Enrollment: | 40 |
| Study Start Date: | January 2008 |
| Estimated Study Completion Date: | December 2008 |
| Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
patients
subjects with right ventricular outflow tract arrhythmia
|
|
control
subjects ,age match,healthy
|
Detailed Description:
The predilection site of idiopathic ventricular arrhythmia is right ventricular outflow tract ,which is called idiopathic RVOT arrhythmia , a retrospective study reported the females are susceptibility to this kind of arrhythmia and another questionaire survey of triggers for RVOT-VT initiation indicated that women have RVOT-A initiation with recognized states of sex hormonal flux , but few researches were made to study the exact relation between this kind of arrhythmia and sex hormone levels, this is the aim of our study .40 females with regular menses(20 females with RVOT arrhythmia ,20 healthy volunteers) will be screened, the Participants will undergo ECG monitoring and their blood samples will be collected at various times throughout the study.
Eligibility| Ages Eligible for Study: | 20 Years to 45 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Women aged 20 to 45 years with regular menstrual cycles.
Inclusion Criteria:
- Must be female
- Aged 20 to 45 years, with regular menstrual cycles.
- With normal BMI
- Without organic heart disease
- Healthy volunteers and women with RVOT arrhythmia are both being recruited.
Exclusion Criteria:
- Pregnancy
- Use of hormonal therapy including birth control pills or other drugs
Contacts and Locations| Contact: Xiaopeng Bai, doctor | 0086-0451-84028663 | bxp007@163.com |
| Contact: Xueqi Li, doctor | 0086-0451-82576775 | lixueqi@medmail.com.cn |
| China, Heilongjiang | |
| Cardiology Department of the 4Th Hospital of Harbin Medical University | Recruiting |
| Harbin, Heilongjiang, China, 150001 | |
| Contact: Xiaopeng Bai, doctor 0086-0451-84028663 bxp007@163.com | |
| Contact: Xueqi Li, doctor 0086-0451-82576775 lixueqi@medmail.com.cn | |
| Sub-Investigator: lingqi Zhou, master | |
| Principal Investigator: Xiaopeng Bai, doctor | |
| Study Director: | Xueqi Li, doctor | the fourth hospital of harbin medical university |
More Information
No publications provided
| Responsible Party: | Bai Xiaopeng, Vasculocardiology Deparment ,The Fourth Hospital of Harbin Medical University |
| ClinicalTrials.gov Identifier: | NCT00606736 History of Changes |
| Other Study ID Numbers: | HMU-007, HMU-008 |
| Study First Received: | January 22, 2008 |
| Last Updated: | February 1, 2008 |
| Health Authority: | China: Ethics Committee |
Keywords provided by Harbin Medical University:
|
right ventricular outflow tract arrhythmia sex hormone level menstrual cycle Gonadal Hormones |
Additional relevant MeSH terms:
|
Arrhythmias, Cardiac Ventricular Premature Complexes Heart Diseases Cardiovascular Diseases Pathologic Processes |
Cardiac Complexes, Premature Hormones Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013